Labetalol and extended-release nifedipine are the two blood pressure medications most widely recommended for use during pregnancy. Both have strong safety records for mother and baby, and they are typically the first options your provider will consider if your blood pressure reaches 140/90 mm Hg or higher. A third option, methyldopa, has been used safely in pregnancy since the 1960s but causes more side effects, so it’s generally considered a backup choice.
Equally important is knowing what to avoid. Some common blood pressure medications can cause serious harm to a developing baby, making the choice of drug during pregnancy a genuinely high-stakes decision.
When Treatment Starts During Pregnancy
Most guidelines define high blood pressure in pregnancy as a reading above 140/90 mm Hg. The American College of Obstetricians and Gynecologists (ACOG) recommends starting medication at that threshold for women who had high blood pressure before pregnancy (chronic hypertension). For gestational hypertension or preeclampsia without severe symptoms, ACOG sets a higher bar of 160/110 mm Hg before initiating treatment, though many international guidelines treat all types at 140/90.
A reading above 159/109 mm Hg is considered a medical emergency requiring treatment within 30 to 60 minutes. This distinction matters because mild-to-moderate high blood pressure and severe hypertension are managed with different approaches, even though the same core medications may be used.
Labetalol: The Most Common First Choice
Labetalol works by blocking both the beta receptors that speed up your heart and the alpha receptors that tighten blood vessels. This dual action lowers blood pressure without dramatically reducing blood flow to the placenta, which is the central concern with any medication during pregnancy.
Unlike some other beta-blockers, labetalol has not been linked to the adverse newborn outcomes seen with older drugs in the same class, such as low birth weight or dangerously slow heart rate in the baby. That distinction is why it’s singled out as the preferred beta-blocker for pregnant patients. It can be taken as a pill for ongoing blood pressure management or given intravenously in the hospital when blood pressure spikes to dangerous levels.
Common side effects for the mother include fatigue, dizziness, and nausea, but most women tolerate it well. Labetalol is also considered compatible with breastfeeding, transferring into breast milk in low amounts that don’t appear to affect infants.
Extended-Release Nifedipine
Nifedipine belongs to a class of drugs called calcium channel blockers. It relaxes the smooth muscle in blood vessel walls, allowing them to widen and reducing pressure. The extended-release form provides steady blood pressure control throughout the day and can be adjusted up to a maximum of 120 mg daily during pregnancy.
A randomized trial in women with severe preeclampsia compared two dosing schedules of extended-release nifedipine and reported no adverse events related to either regimen. It’s a well-tolerated option, though some women experience flushing, headache, or swelling in the ankles. Nifedipine is also the top recommendation for breastfeeding mothers among calcium channel blockers. Infants receive roughly 0.1% of the mother’s weight-adjusted dose through breast milk, a negligible amount.
Methyldopa: A Reliable Backup
Methyldopa works in the brain, dialing down the nerve signals that raise blood pressure. It has been used in pregnancy since the 1960s with no evidence of birth defects, giving it one of the longest safety track records of any blood pressure drug in this setting. It remains widely used in lower-income countries because it’s inexpensive.
The reason it’s now considered second-line rather than first-line comes down to how it makes the mother feel. Common side effects include drowsiness, dry mouth, dizziness, and headache. These can be significant enough to interfere with daily life, especially during a pregnancy that may already involve fatigue. Rare but serious complications include a type of immune-triggered anemia (detected by a routine blood test) and liver problems, both of which resolve when the drug is stopped. For women who can’t tolerate labetalol or nifedipine, methyldopa remains a solid alternative.
Medications That Are Dangerous During Pregnancy
Two widely prescribed categories of blood pressure drugs are strictly off-limits during pregnancy: ACE inhibitors (names ending in “-pril,” like lisinopril or enalapril) and ARBs (names ending in “-sartan,” like losartan or valsartan). These medications interfere with a hormone system that plays a critical role in fetal kidney development and fluid balance.
Exposure during pregnancy has been linked to skull defects, kidney failure in the fetus, dangerously low amniotic fluid levels, low blood pressure in the newborn, and fetal death. These risks are so well established that both drug classes are considered completely contraindicated at every stage of pregnancy. If you’re taking either type and become pregnant or are planning to conceive, switching to a pregnancy-safe option beforehand is essential.
Some other beta-blockers beyond labetalol, particularly atenolol, also raise concerns. Atenolol has been associated with lower birth weight and accumulates heavily in breast milk, with infant blood levels reaching nearly 19% of the mother’s level. It’s generally avoided in both pregnancy and breastfeeding.
What the Research Shows About Long-Term Effects on Children
A systematic review covering nearly 6,000 children found that neither labetalol nor methyldopa was associated with impaired brain development. This is reassuring, given how many pregnancies involve these drugs. One small trial of 170 children did find slightly poorer fine motor skills in those exposed to nifedipine before birth, though the finding hasn’t been confirmed in larger studies.
A more recent large study found that children exposed to blood pressure medication before birth had modestly higher rates of learning and communication difficulties, but children of mothers with untreated high blood pressure showed similar patterns. In other words, much of this association likely reflects the effects of the high blood pressure itself rather than the medication. One finding stood out: prenatal beta-blocker exposure was linked to a higher rate of autism spectrum diagnosis (about twice the odds), an association that wasn’t seen with untreated hypertension alone or with other drug classes. This is a single observational study that can’t prove cause and effect, and it needs replication, but it’s worth being aware of as research continues.
Choosing Between Options
In practice, the choice between labetalol and nifedipine often comes down to your individual health profile. Women with asthma generally do better with nifedipine, since beta-blockers can narrow the airways. Women who experience significant flushing or headaches with nifedipine may prefer labetalol. Some women end up taking both if a single drug doesn’t bring blood pressure into a safe range.
If you were on a different blood pressure medication before pregnancy, the transition typically happens early, ideally before conception or as soon as pregnancy is confirmed. The goal is straightforward: keep your blood pressure below a level that threatens you or your baby, using a drug with decades of safety data behind it.